<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2007-6-19-23</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-876</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТРАВМА. КРОВОПОТЕРЯ. ШОК</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INJURY. BLOOD LOSS, SHOCK</subject></subj-group></article-categories><title-group><article-title>С-реактивный белок и цитокины при политравме</article-title><trans-title-group xml:lang="en"><trans-title>C-Reactive Protein and Cytokines in Polytrauma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуманенко</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Gumanenko</surname><given-names>E. K</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Немченко</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Nemchenko</surname><given-names>N. S</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бояринцев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Boyarintsev</surname><given-names>V. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаврилин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gavrilin</surname><given-names>S. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вологжанин</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vologzhanin</surname><given-names>D. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рудь</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rud</surname><given-names>A. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кафедра военно-полевой хирургии Военно-медицинской академии, Санкт-Петербург</institution></aff><aff xml:lang="en"><institution>Department of Battle-Field Surgery, Military Medical Academy, Saint Petersburg</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2007</year></pub-date><volume>3</volume><issue>6</issue><issue-title>Том III № 5-6 2007 г.</issue-title><fpage>19</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гуманенко Е.К., Немченко Н.С., Бояринцев В.В., Гаврилин С.В., Вологжанин Д.А., Рудь А.А., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Гуманенко Е.К., Немченко Н.С., Бояринцев В.В., Гаврилин С.В., Вологжанин Д.А., Рудь А.А.</copyright-holder><copyright-holder xml:lang="en">Gumanenko E.K., Nemchenko N.S., Boyarintsev V.V., Gavrilin S.V., Vologzhanin D.A., Rud A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/876">https://www.reanimatology.com/rmt/article/view/876</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования . Изучение связи С-реактивного белка (C-РБ) с цитокинами при политравме.</p><p>Материалы и методы исследования. Обследовали 84 пострадавших с тяжелой сочетанной травмой. У 25 пациентов (29,7%) развился сепсис, из них летальный исход отмечался в 83,3%. C-РБ определяли в сыворотке крови пострадавших ежедневно с помощью наборов CRP latex test (Germany, HUMATEX). IL-2, IL-4, TNFa, IFNy, HLA-DR исследовали в 1, 3, 7, 10, 15-е сутки после травмы в сыворотке крови и в культуре лимфоцитов на автоматическом иммуноферментном анализаторе (Elx 800 Universal Microplate Reader, BIO-TEK INSTRUMENTS, INC. USA) с помощью иммуноферментных тест-систем (ООО «Цитокин», Санкт-Петербург, Россия).</p></sec><sec><title>Результаты исследования</title><p>Результаты исследования. При C-РБ 40 мг/л в 1-е сутки и последующем его снижении осложнения не наблюдались. Уровень C-РБ 40 мг/л в 1-е сутки (в условиях неприменения глюкокортикоидов) и пролонгированное его повышение определяли при висцеральных воспалительно-инфекционных осложнениях. C-РБ 120 мг/л в первые 7 суток отмечался при развившемся в последующем сепсисе. Глюкокор-тикоиды и специфические иммунные препараты приводили к снижению или полному исчезновению C-РБ. С их отменой с-рб появлялся в количестве, отражающем эффект лечения. При отсутствии полиорганной несостоятельности со снижением инфекционного процесса снижался уровень C-РБ. Низкий уровень C-РБ и активация инфекционного процесса свидетельствовали об ареактивности организма. При C-РБ 40 мг/л спонтанная продукция и уровень в крови IL-4 повышались менее значительно, а IFNy — более значительно, чем при C-РБ 40 мг/л; индуцированная активность TNFa также более резко снижалась при C-РБ 40 мг/л (в 10 раз против 2,2). Независимо от уровня с-рб индуцированная активность IL-4 снижалась на 59%, свидетельствуя об иммунодепрессии. Связь C-РБ с IL-2 и HLA-DR не определялась.</p></sec><sec><title>Заключение</title><p>Заключение. Ежедневный анализ С-РБ в крови позволяет прогнозировать при травме висцеральные воспалительно-инфекционные осложнения и сепсис. Ингибирование С-реактивным белком противовоспалительных свойств IL-4 приводит к неконтролируемому системному воспалительному ответу. Характер взаимосвязи IL-4, TNFa, IFNy и C-РБ следует учитывать в лечении посттравматического сепсиса.</p></sec><sec><title> </title><p> </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to study the association of C-reactive protein (CRP) with cytokines in polytrauma.</p></sec><sec><title>Subjects and methods</title><p>Subjects and methods. Eighty-four victims with severe concomitant injury were examined. Twenty-five (29.7%) patients developed sepsis, death being observed in 83.3%. CRP was daily determined in the sera of the victims, by using CRP latex test kits (HUMATEX, Germany). On days 1, 3, 7, 10, and 15 after injury, serum and lymphocytic culture IL-2, IL-4, TNF-a, IFN-y, and HLA-DR were studied on an automatic Elx 800 Universal Microplate Reader enzyme immunoassay analyzer (BIO-TEK INSTRUMENTS, Inc., USA), by applying enzyme immunoassay systems (OOO «Cytokine», Saint Petersburg, Russia).</p></sec><sec><title>Results</title><p>Results. No complications were observed with a CRP level of 40 mg/l on day 1 and its further reduction. The CRP level of 40 mg/l on day 1 (without use of glucocorticoids) and its prolonged increase were determined in visceral inflammatory and infectious complications. The CRP level of 120 mg/l within the first 7 days was noted in subsequently developed sepsis. Glucocorticoids and specific immune drugs resulted in a reduction or complete disappearance of CRP. When the latter were discontinued, CRP appeared in the quantity reflecting the effect of treatment. In the absence of multiple organ dysfunctions, the level of CRP decreased as the infectious process diminished. The low level of CRP and the activation of an infectious process suggest the areactivity of an organism. With the CRP level of 40 mg/l, the spontaneous production and level of blood IL-4 increased less significantly, whereas those of IFN-y rose more substantially; the induced activity of TNF-a also more drastically decreased (by 10 times versus 2.2) with a CRP level of 40 mg/l. Irrespective of the level of CRP, the induced activity of IL-4 decreased by 59%, suggesting immunosuppression. There was no association of CRP with IL-2 and HLA-DR.</p></sec><sec><title>Conclusion</title><p>Conclusion. Daily blood CRP analysis in injury makes it possible to predict visceral inflammatory infectious complications and sepsis. CRP inhibition of the anti-inflammatory properties of IL-4 causes an uncontrolled systemic inflammatory response. The pattern of relationships of IL-4, TNF-a, IFN-y, and CRP should be borne in mind when posttraumatic sepsis is treated.</p></sec><sec><title> </title><p> </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>C-реактивный белок</kwd><kwd>политравма</kwd><kwd>синдром системного воспалительного ответа</kwd><kwd>сепсис</kwd><kwd>цитокины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>C-reactive proteinж polytrauma</kwd><kwd>systemic inflammatory response syndrome</kwd><kwd>sepsis</kwd><kwd>cytokines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Галкина Е. В. Взаимодействие между С-reactive protein, сывороточным амилоидом Р и интерлейкином-8 и их роль в регуляторной функции нейтрофилов: автореф. дис…. канд. мед. наук. СПб.; 1998.</mixed-citation><mixed-citation xml:lang="en">Галкина Е. В. Взаимодействие между С-reactive protein, сывороточным амилоидом Р и интерлейкином-8 и их роль в регуляторной функции нейтрофилов: автореф. дис…. канд. мед. наук. СПб.; 1998.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cunha J., Gloria C., Vilela H., Lopes V. C-reactive protein: a good parameter for sepsis diagnosis. Intens. Care Med. 1997; 23 (509): 27—34.</mixed-citation><mixed-citation xml:lang="en">Cunha J., Gloria C., Vilela H., Lopes V. C-reactive protein: a good parameter for sepsis diagnosis. Intens. Care Med. 1997; 23 (509): 27—34.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Исаков Д. В. Влияние С-реактивного белка на передачу сигналов от интерлейкина-4: автореф. дис….канд. мед. наук. СПб.; 2001.</mixed-citation><mixed-citation xml:lang="en">Исаков Д. В. Влияние С-реактивного белка на передачу сигналов от интерлейкина-4: автореф. дис….канд. мед. наук. СПб.; 2001.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Вoeken U., Feindt P.,Mohan E., Gams E. The effect of an increased preoperative CRP-value on septic complications after extracorporeal circulation. Shock 1997; 7 (Suppl.): 11.</mixed-citation><mixed-citation xml:lang="en">Вoeken U., Feindt P.,Mohan E., Gams E. The effect of an increased preoperative CRP-value on septic complications after extracorporeal circulation. Shock 1997; 7 (Suppl.): 11.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Flores J., Jimenez P., Rincon D. et al. C-reactive protein as marker of infection among patients with severe closed trauma. Enferm. Infec. Microbiol. Clin. 2001; 5 (2): 61—65.</mixed-citation><mixed-citation xml:lang="en">Flores J., Jimenez P., Rincon D. et al. C-reactive protein as marker of infection among patients with severe closed trauma. Enferm. Infec. Microbiol. Clin. 2001; 5 (2): 61—65.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fujimi S., Ogura H., Tanaka H. et al. Activated polymorphonuclear leucocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. Trauma 2002; 52 (3): 443—448.</mixed-citation><mixed-citation xml:lang="en">Fujimi S., Ogura H., Tanaka H. et al. Activated polymorphonuclear leucocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. Trauma 2002; 52 (3): 443—448.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ogura H., Kawasaki T., Tanaka H. et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. Trauma 2001; 50 (5): 801—809.</mixed-citation><mixed-citation xml:lang="en">Ogura H., Kawasaki T., Tanaka H. et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. Trauma 2001; 50 (5): 801—809.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sobieska M., Mikstacki A., Wiktorowicz K. Selected acute phase proteins in patients with polytrauma. Shock 1997; 7(Suppl.): 15.</mixed-citation><mixed-citation xml:lang="en">Sobieska M., Mikstacki A., Wiktorowicz K. Selected acute phase proteins in patients with polytrauma. Shock 1997; 7(Suppl.): 15.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lasson A., Gorransson J., Jonson S. High preoperative acute phase proteins indicate an increased risk of postoperative complications. Shock 1997; 7 (Suppl.): 11.</mixed-citation><mixed-citation xml:lang="en">Lasson A., Gorransson J., Jonson S. High preoperative acute phase proteins indicate an increased risk of postoperative complications. Shock 1997; 7 (Suppl.): 11.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Luiking Y., Steens N., Ramsay G., Deutz N. In vivo nitric oxide production is elevated both in moderate and severe inflammatory states. Shock 2004; 21 (Suppl.): 96.</mixed-citation><mixed-citation xml:lang="en">Luiking Y., Steens N., Ramsay G., Deutz N. In vivo nitric oxide production is elevated both in moderate and severe inflammatory states. Shock 2004; 21 (Suppl.): 96.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Takala A., Jousela L., Olkkola K. et al. Levels of CD 11b expression and plasma interleukin-6 predict organ failure in sepsis. Shock 1997; 7 (Suppl.): 12.</mixed-citation><mixed-citation xml:lang="en">Takala A., Jousela L., Olkkola K. et al. Levels of CD 11b expression and plasma interleukin-6 predict organ failure in sepsis. Shock 1997; 7 (Suppl.): 12.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
